Back to Search Start Over

Bariatric surgery and calcifediol treatment, Gordian knot of severe-obesity-related comorbidities treatment.

Authors :
Herrera-Martínez AD
Castillo-Peinado LLS
Molina-Puerta MJ
Calañas-Continente A
Membrives A
Castilla J
Camacho Cardenosa M
Casado-Díaz A
Gálvez-Moreno MA
Gahete MD
Quesada Gómez JM
Bouillon R
Priego-Capote F
Luque RM
Source :
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Oct 06; Vol. 14, pp. 1243906. Date of Electronic Publication: 2023 Oct 06 (Print Publication: 2023).
Publication Year :
2023

Abstract

Background: Obesity (OB) is a chronic metabolic disease with important associated comorbidities and mortality. Vitamin D supplementation is frequently administered after bariatric surgery (BS), so as to reduce OB-related complications, maybe including chronic inflammation.<br />Aim: This study aimed to explore relations between vitamin D metabolites and components of the inflammasome machinery in OB before and after BS and their relations with the improvement of metabolic comorbidities.<br />Patients and Methods: Epidemiological/clinical/anthropometric/biochemical evaluation was performed in patients with OB at baseline and 6 months after BS. Evaluation of i) vitamin-D metabolites in plasma and ii) components of the inflammasome machinery and inflammatory-associated factors [NOD-like-receptors (NLRs), inflammasome-activation-components, cytokines and inflammation/apoptosis-related components, and cell-cycle and DNA-damage regulators] in peripheral blood mononuclear cells (PBMCs) was performed at baseline and 6 months after BS. Clinical and molecular correlations/associations were analyzed.<br />Results: Significant correlations between vitamin D metabolites and inflammasome-machinery components were observed at baseline, and these correlations were significantly reduced 6 months after BS in parallel to a decrease in inflammation markers, fat mass, and body weight. Treatment with calcifediol remarkably increased 25OHD levels, despite 24,25(OH) <subscript>2</subscript> D <subscript>3</subscript> remained stable after BS. Several inflammasome-machinery components were associated with improvement in metabolic comorbidities, especially hypertension and dyslipidemia.<br />Conclusion: The beneficial effects of vitamin D on OB-related comorbidities after BS patients are associated with significant changes in the molecular expression of key inflammasome-machinery components. The expression profile of these inflammasome components can be dynamically modulated in PBMCs after BS and vitamin D supplementation, suggesting that this profile could likely serve as a sensor and early predictor of the reversal of OB-related complications after BS.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Herrera-Martínez, Castillo-Peinado, Molina-Puerta, Calañas-Continente, Membrives, Castilla, Camacho Cardenosa, Casado-Díaz, Gálvez-Moreno, Gahete, Quesada Gómez, Bouillon, Priego-Capote and Luque.)

Details

Language :
English
ISSN :
1664-2392
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in endocrinology
Publication Type :
Academic Journal
Accession number :
37867510
Full Text :
https://doi.org/10.3389/fendo.2023.1243906